https://regulatorynews.com/omass-therapeutics-series-c-financing Regulatory News en 2026-10-18T09:34:20-04:00 OMass Therapeutics Raises $310M Series C https://regulatorynews.com/opus-genetics-ryzumvi-presbyopia-approval Regulatory News en 2026-10-18T09:34:20-04:00 Opus Genetics Wins Second FDA Nod for RYZUMVI https://regulatorynews.com/simbiosys-tumorsight-risk-fda-clearance Regulatory News en 2026-10-18T09:34:20-04:00 SimBioSys Earns FDA Clearance for TumorSight Risk https://regulatorynews.com/alcon-brytly-apraclonidine-otc-approval Regulatory News en 2026-10-18T05:55:27-04:00 FDA Clears First OTC Apraclonidine Drop, Alcon's Brytly https://regulatorynews.com/fda-ectd-validation-rejection-january-2027 Regulatory News en 2026-10-18T05:55:27-04:00 FDA Sets Jan. 2027 Cutoff to Reject Bad eCTD Submissions https://regulatorynews.com/mhra-antidepressant-boxed-warning-review Regulatory News en 2026-10-18T05:55:27-04:00 MHRA Orders Boxed Suicide-Risk Warning on Antidepressants https://regulatorynews.com/daraxonrasib-first-ras-inhibitor-pancreatic-cancer Regulatory News en 2026-10-17T10:50:36-04:00 EMA Recommends First RAS Inhibitor for Pancreatic Cancer https://regulatorynews.com/ascendis-pharma-yuviwel-achondroplasia-chmp-opinion Regulatory News en 2026-10-17T09:39:56-04:00 Ascendis Wins CHMP Backing for Achondroplasia Drug Yuviwel https://regulatorynews.com/centinel-spine-prodisc-c-nova-two-level-approval Regulatory News en 2026-10-17T09:39:56-04:00 Centinel Spine Completes 2-Level Cervical Disc Set https://regulatorynews.com/marengo-therapeutics-invikafusp-alfa-fast-track-expansion Regulatory News en 2026-10-17T09:39:56-04:00 Marengo Earns Second FDA Fast Track for Tumor Drug https://regulatorynews.com/ema-rasonque-chmp-opinion Regulatory News en 2026-10-17T05:58:51-04:00 EMA Recommends EU Approval for RAS-Inhibitor Rasonque https://regulatorynews.com/enspryng-ted-at-home-approval Regulatory News en 2026-10-17T05:58:51-04:00 FDA Approves Enspryng as First At-Home TED Treatment https://regulatorynews.com/par-health-argatroban-recall Regulatory News en 2026-10-17T05:58:51-04:00 Par Health Recalls Argatroban Over Particulate Matter